— Know what they know.
Not Investment Advice

NMRD OTC

Nemaura Medical Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -100.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Neutral · Power 51 · $4035 mcap · 17M float · 0.0069% daily turnover · Short 86% of daily vol

Balance Sheet Trends

Total Assets
$15M -34.1% ▼
5Y CAGR: +18.4%
Total Liabilities
$26M +21.9% ▲
5Y CAGR: +65.2%
Shareholders Equity
-$12M -2634.8% ▼
Cash & Investments
$10M -43.1% ▼
5Y CAGR: +12.0%
Total Debt
$20M +4.4% ▲
Net Debt
$10M +589.5% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2019FY2020FY2021FY2022FY2023
— Assets —
Cash$4M$106K$32M$18M$10M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$4M$106K$32M$18M$10M
Net Receivables$0$101K$89K$101K$410K
Inventory$38K$286K$851K$1M$2M
Other Current Assets$0$0$0$0$358K
Total Current Assets$5M$845K$34M$20M$14M
Property, Plant & Equip.$57K$162K$202K$533K$642K
Goodwill & Intangibles$192K$213K$1M$1M$384K
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets-$249K$0$0$0$0
Total Non-Current Assets$249K$375K$1M$2M$1M
Total Assets$5M$1M$35M$22M$15M
— Liabilities —
Accounts Payable$161K$294K$254K$136K$327K
Short-Term Debt$0$0$6M$19M$17M
Deferred Revenue$65K$93K$103K$259K$124K
Other Current Liabilities$0$0$0$440K$4M
Total Current Liabilities$1M$1M$6M$21M$22M
Long-Term Debt$0$0$19M$0$3M
Other Non-Current Liab.$0$0-$19M$0-$3M
Total Non-Current Liabilities$1M$1M$20M$1M$4M
Total Liabilities$3M$3M$27M$22M$26M
— Equity —
Common Stock$21K$21K$23K$24K$29K
Retained Earnings-$13M-$18M-$24M-$38M-$52M
Accumulated OCI-$340K-$337K$136K-$122K-$959K
Total Stockholders Equity$2M-$1M$8M$466K-$12M
Total Liabilities & Equity$5M$1M$35M$22M$15M
— Key Metrics —
Total Debt$0$0$25M$19M$20M
Net Debt-$4M-$106K-$7M$1M$10M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms